SG Austria has teamed up with the world’s leading experts in cell encapsulation to put together a comprehensive book entitled “Bioencapsulation of Living Cells for Diverse Medical Applications” on the current state of the art in this subject area. The book was edited by Dr. John Dangerfield, COO of SG Austria and Dr. Eva Maria (Lilli) Brandtner, Scientific Advisor at SG Austria/Austrianova Singapore and Head of the Bioencapsulation Unit at the Vorarlberg Institute for Vascular Investigation and Treatment (VIVIT). Topics covered by the book include the use of cell encapsulation for the treatment of diabetes, diseases of the central nervous system such as epilepsy, Parkinson’s, Alzheimer’s and Huntington’s disease. It also contains a chapter written by the SG Austria team and collaborators on more recent uses of the technology for the release of antibodies and how cell microencapsulation can help stem cells unfold their full potential. Ongoing and future developments are covered such as how elaborate molecular switches can enable encapsulated cells to release bio-active molecules on demand in the desired quantity at the required site in the body and stay functional over a long period of time as well as a technique to produce extraordinarily small microcapsules and their advantages in terms of volume to surface ratio which leads to improved diffusion characteristics and offers favorable biocompatibility as well as mechanical stability. Last but not least, it offers an introduction into the different materials and techniques summarized by the term “bioencapsulation” and provide laboratory protocols for the core procedures carried out by the “encapsulator”.
Dr. Brian Salmons, CEO of SG Austria said, “We are pleased that our leading partners as well as competitors have contributed to this state of the art book which has been so professionally edited by my two colleagues, Dr. Brandtner and
Click here for the complete issue.